Carson Wealth (CWM LLC)
RCUS icon

Carson Wealth (CWM LLC)’s Arcus Biosciences RCUS Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$116K Buy
5,354
+33
+0.6% +$713 ﹤0.01% 3139
2025
Q4 		$127K Sell
5,321
-42
-0.8% -$857 ﹤0.01% 2893
2025
Q3 		$73K Sell
5,363
-78
-1% -$811 ﹤0.01% 3220
2025
Q2 		$44K Buy
5,441
+3,810
+234% +$32.5K ﹤0.01% 3383
2025
Q1 		$13K Buy
1,631
+1,161
+247% +$13.5K ﹤0.01% 3968
2024
Q4 		$7K Buy
470
+7
+2% +$114 ﹤0.01% 4074
2024
Q3 		$7K Buy
463
+84
+22% +$1.32K ﹤0.01% 3963
2024
Q2 		$6K Buy
379
+24
+7% +$387 ﹤0.01% 3800
2024
Q1 		$7K Buy
355
+169
+91% +$2.92K ﹤0.01% 3533
2023
Q4 		$4K Sell
186
-39
-17% -$623 ﹤0.01% 3623
2023
Q3 		$4K Sell
225
-100
-31% -$2.01K ﹤0.01% 3589
2023
Q2 		$7K Buy
325
+292
+885% +$5.56K ﹤0.01% 3298
2023
Q1 		$1K Sell
33
-540
-94% -$10.3K ﹤0.01% 3904
2022
Q4 		$12K Buy
573
+180
+46% +$4.95K ﹤0.01% 2710
2022
Q3 		$10K Buy
393
+320
+438% +$8.46K ﹤0.01% 2695
2022
Q2 		$2K Buy
+73
New +$1.79K ﹤0.01% 3391
2022
Q1 		– Sell
-10
Closed – – 3813
2021
Q4 		$0 Buy
+10
New +$388 ﹤0.01% 3620

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RCUS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Arcus Biosciences (RCUS) stake by 0.62% in Q1 2026, buying an estimated $713 and bringing the position to 5,354 shares worth $116K. The position accounts for ﹤0.01% of the portfolio, ranked #3139.

Carson Wealth (CWM LLC) first reported a position in RCUS in Q4 2021 and has held it in 17 quarters since. The position peaked at $127K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Carson Wealth (CWM LLC) held 5,354 shares of Arcus Biosciences worth $116K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 33 Arcus Biosciences shares in Q1 2026, an estimated $713.
  • Arcus Biosciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3139 holding.
  • Carson Wealth (CWM LLC) first reported a position in Arcus Biosciences in Q4 2021 and has held it in 17 quarters since.
  • Carson Wealth (CWM LLC)'s Arcus Biosciences position peaked at $127K in Q4 2025.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.